Gene: SPRING1
Official Full Name: SREBF pathway regulator in golgi 1provided by HGNC
Gene Summary: Involved in positive regulation of SREBP signaling pathway. Located in Golgi membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20850 | SPRING1 Knockout cell line (HeLa) | Human | SPRING1 | 1:3~1:6 | Negative | Online Inquiry |
KO20851 | SPRING1 Knockout cell line (HCT 116) | Human | SPRING1 | 1:2~1:4 | Negative | Online Inquiry |
KO20852 | SPRING1 Knockout cell line (HEK293) | Human | SPRING1 | 1:3~1:6 | Negative | Online Inquiry |
KO20853 | SPRING1 Knockout cell line (A549) | Human | SPRING1 | 1:3~1:4 | Negative | Online Inquiry |
SPRING1 Gene Knockout Cell Lines are a cutting-edge research tool designed for the investigation of SPRING1 gene function in various biological processes. These cell lines have been engineered using CRISPR-Cas9 technology to create specific, targeted deletions of the SPRING1 gene, enabling the study of its role in cellular mechanisms such as transcription regulation, cell proliferation, and apoptosis. By providing a controlled environment where the SPRING1 gene is inactivated, researchers can explore aberrations caused by the loss of this gene, potentially linking it to various pathologies, including cancer.
The functionality of SPRING1 Gene Knockout Cell Lines is rooted in the precise genomic editing afforded by CRISPR technology. When the SPRING1 gene is knocked out, researchers can monitor downstream effects on cellular pathways, furthering our understanding of gene-gene interactions and signaling cascades. These insights are vital in both basic research and translational studies, facilitating the development of targeted therapies and novel diagnostic tools.
Scientifically, SPRING1 Gene Knockout Cell Lines play a prominent role in advancing our knowledge of gene function and disease mechanisms. Their applications span across diverse fields, including molecular biology, genetics, and pharmacology, making them invaluable in the quest for personalized medicine. Compared to other products on the market, these cell lines offer unique advantages such as high specificity in gene disruption, reduced off-target effects, and extensive validation for consistent results across different research conditions.
For researchers and clinicians seeking reliable models to interrogate the role of SPRING1 in health and disease, the SPRING1 Gene Knockout Cell Lines provide a robust framework. They streamline experimental workflows, enhance reproducibility, and ultimately foster breakthroughs in understanding gene functionalities and developing interventions aimed at mitigating SPRING1-related disorders. Our company boasts a rich history of innovation in genetic engineering and commitment to excellence, ensuring that the SPRING1 Gene Knockout Cell Lines meet the highest standards of scientific rigor and reliability for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.